Sierra-Johnson et al. investigated Taiwanese women (150 breast cancer patients before treatment and 71 healthy controls), and showed that breast cancer patients had significantly lower apoA levels and apoA-I/apoB ratios than controls [11]. This evidence concerns the gene APOA1 and breast cancer.